Stock Evaluator: Astrana Health, Inc. (ASTH)

Astrana Health, Inc. ASTH

$35.11 1.56 4.65%
September 22, 2026 4:00:00 PM EST November 10, 2021 Volume: 409,443
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Providers & Services

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1992 and is headquartered in Alhambra, California.

Commentary & Analysis


Financial Summary

Share Statistics ASTH Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $1,716.9 $1,722.4 52%
Shares Out (Mil) 49.8 73.7 47%
Institutional Ownership 85.5% 86.8% 53%
Float (Mil) 38.8 53.9 41%
Beta 0.90 0.81 54%
Avg Daily Volume (000s) 495 631 56%
Price Change
(52-week)
12.6% 79.2% 62%
Growth ASTH Industry
Median
Percentile
(All Stocks)
Sales (5yr) 35.9% 10.4% 92%
Net Income (5yr) (9.8%) (0.1%) 29%
EPS (5yr) (14.6%) 3.1% 19
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) 3.7% (18.0%) 67%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 3 3 3
Current EPS $0.877 $3.067 $3.637
Month Ago EPS $0.860 $3.040 $3.540
# Rev Up 0 1 1
# Rev Down 0 0 0
Three Months Ago EPS $0.790 $2.920 $3.410
Year/Year Chg 119.3% 569.7% 889.1%
Financials ASTH Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $3,844 $1,503 70%
Net Income (TTM) (Mil) $41 $26 53%
EPS (TTM) $0.825 $0.200 59%
Operating Cash Flow (TTM) (Mil) $108 $141 53%
Net Cash Flow (TTM) (Mil) $65 $5 73%
Long-Term Debt (Q1) (Mil) $917 $356 65%
Enterprise Value (Q1) (Mil) $2,361 $2,284 51%
Valuation ASTH Industry
Median
Percentile
(All Stocks)
P/B 1.99 3.02 51%
P/E 40.9 25.0 81%
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 1.0 na
Ratios ASTH Industry
Median
Percentile
(All Stocks)
Gross Margin 10.5% 27.9% 10%
Net Margin 1.1% 1.3% 35%
ROA 2.2% 2.2% 56%
ROE 5.1% 7.0% 44%
Liabilities to Assets 73.8% 61.3% 69%
F-Score 6 5 67%

Astrana Health, Inc. did not pass any screens on 9/21/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors